Abstract:BACKGROUND:Human infection caused by the avian influenza A H7N9 virus has a case-fatality rate of over 30%. Systematic study of the pathogenesis of avian H7N9 isolate and effective therapeutic strategies are needed. METHODS:BALB/c mice were inoculated intranasally with an H7N9 virus isolated from a chicken in a wet market epidemiologically linked to a fatal human case, (A/chicken/Zhejiang/DTID-ZJU01/2013 [CK1]), and with an H7N9 virus isolated from a human (A/Anhui/01/2013 [AH1]). The pulmonary viral loads, cytokine/chemokine profiles and histopathological changes of the infected mice were compared. The therapeutic efficacy of a non-steroidal anti-inflammatory drug (NSAID), celecoxib, was assessed. RESULTS:Without prior adaptation, intranasal inoculation of 106 plaque forming units (PFUs) of CK1 caused a mortality rate of 82% (14/17) in mice. Viral nucleoprotein and RNA expression were limited to the respiratory system and no viral RNA could be detected from brain, liver and kidney tissues. CK1 caused heavy alveolar inflammatory exudation and pulmonary hemorrhage, associated with high pulmonary levels of proinflammatory cytokines. In the mouse lung cell line LA-4, CK1 also induced high levels of interleukin-6 (IL-6) and cyclooxygenase-2 (COX-2) mRNA. Administration of the antiviral zanamivir did not significantly improve survival in mice infected with CK1, but co-administration of the non-steroidal anti-inflammatory drug (NSAID) celecoxib in combination with zanamivir improved survival and lung pathology. CONCLUSIONS:Our findings suggested that H7N9 viruses isolated from chicken without preceding trans-species adaptation can cause lethal mammalian pulmonary infection. The severe proinflammatory responses might be a factor contributing to the mortality. Treatment with combination of antiviral and NSAID could ameliorate pulmonary inflammation and may improve survival.

Multiple Amino Acid Substitutions Are Involved in the Adaptation of H9N2 Avian Influenza Virus to Mice.

Multiple Amino Acid Substitutions Involved in the Adaptation of Avian-Origin Influenza A (H10N7) Virus in Mice

Amino Acid Substitutions HA A150V, PA A343T, and PB2 E627K Increase the Virulence of H5N6 Influenza Virus in Mice

Amino Acid Substitutions Involved in the Adaptation of a Novel H7N7 Avian Influenza Virus in Mice.

Adaptive Amino Acid Substitutions Enhance the Virulence of an Avian-Origin H6N1 Influenza Virus in Mice

Amino Acid Substitutions Involved in the Adaptation of a Novel Highly Pathogenic H5N2 Avian Influenza Virus in Mice

Virulence of an H5N8 Highly Pathogenic Avian Influenza is Enhanced by the Amino Acid Substitutions PB2 E627K and HA A149V.

Rapid Emergence of a PB2 D701N Substitution During Adaptation of an H9N2 Avian Influenza Virus in Mice

Multiple amino acid substitutions involved in enhanced pathogenicity of LPAI H9N2 in mice.

Amino Acid Substitutions Occurring During Adaptation of an Emergent H5N6 Avian Influenza Virus to Mammals.

Mutual antagonism of mouse-adaptation mutations in HA and PA proteins on H9N2 virus replication

Insights into the increasing virulence of the swine-origin pandemic H1N1/2009 influenza virus

Increased virulence of a novel reassortant H1N3 avian influenza virus in mice as a result of adaptive amino acid substitutions

Amino acid mutations PB1-V719M and PA-N444D combined with PB2-627K contribute to the pathogenicity of H7N9 in mice

The Effect of Mice Adaptation Process on the Pathogenicity of Influenza A/South Africa/3626/2013 (H1N1)pdm09 Model Strain

Mouse Lung‐adapted Mutation of E190G in Hemagglutinin from H5N1 Influenza Virus Contributes to Attenuation in Mice

139D in NS1 Contributes to the Virulence of H5N6 Influenza Virus in Mice

Variation and Molecular Basis for Enhancement of Receptor Binding of H9N2 Avian Influenza Viruses in China Isolates

Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor.

Identification of amino acids in highly pathogenic avian influenza H5N1 virus hemagglutinin that determine avian influenza species specificity

The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication